Search

everythinglearnresearchcommunity

for

Search:↓

Tofacitinib and adalimumab are promising treatments for cicatricial alopecia with few side effects.

Both treatments for alopecia areata showed similar modest effectiveness.

Pulse corticosteroids help regrow hair in alopecia areata but have side effects, especially betamethasone.

Hair loss greatly affects quality of life, and dermatologists are crucial for proper diagnosis and treatment.

Dupilumab may help hair regrowth in some patients with severe atopic dermatitis, but results vary.

The Middle East and Africa need better data, treatment consensus, and support for Alopecia Areata.

Alopecia causes significant emotional distress and psychological issues, requiring combined skin and mental health treatment.

Lower GPX4 mRNA levels are linked to higher disease activity and symptoms in lupus patients.

Low-level laser therapy may help with hair regrowth in alopecia areata but its effectiveness for psoriasis and atopic dermatitis needs more research.

Female authorship in dermatology publications increased during the COVID-19 pandemic, but women are still underrepresented in senior roles.

More research with diverse participants is needed to determine the effectiveness of photobiomodulation devices for hair loss treatment.

Red clover extract-based scalp treatments significantly improved hair volume and reduced hair loss and damage.

Vitiligo is often found with other autoimmune diseases, which is important to know to help patients.

Eyebrow hair transplants in patients with frontal fibrosing alopecia may look good at first but often lose the new hair after a few years.

Targeting cholesterol, fatty acids, fibrosis, and mast cells may help treat CCCA.

Mindfulness reduces anxiety and depression in skin disease patients; dermatologists and psychiatrists often lack confidence in treating psychodermatological conditions.

Hair regrowth was seen in 83% of children with alopecia, immune system plays a role in the condition, and various treatments showed effectiveness for hair and nail disorders.

Botulinum toxin type A significantly reduces scalp psoriasis severity compared to placebo.

Hidradenitis Suppurativa is likely an autoinflammatory disease, and better understanding its causes could improve treatments.

Psoriasis patients experience moderate functional impairment related to disease severity and less satisfaction.

10% carbamide peroxide is safe and effectively reduces mild to moderate acne.

People with hidradenitis suppurativa who are more resilient tend to have better quality of life and less anxiety and depression.

Most patients with cutaneous dermatomyositis either improved or remained stable over 3.5 years.

Laser treatment may help with hair growth in some people with frontal fibrosing alopecia, but results vary and the exact way it works is unclear.

The congress showed that psychological therapy can help skin condition patients, social media affects acne stigma, education improves atopic dermatitis, and patient satisfaction in dermatology is high, especially with good doctor engagement.

New factors in female hair loss include genetics, hormones, stress, and inflammation; future treatments should also focus on these areas and consider the patient's emotional well-being.

Cleanroom workers in a battery factory have worse skin and eye conditions due to the very dry environment.

Sleep problems and skin issues affect each other; poor sleep can worsen skin conditions, and some skin treatments can improve or harm sleep quality.

A child on life support experienced rapid hair loss due to severe illness affecting hair growth.

Online medical education helps doctors make better clinical decisions and increases their knowledge in treating fungal nail infections.